drugset / Trial / NCT05740371
Safety of Argatroban Infusion in Conduction Disturbances
NaSingle-groupOpen-labelTreatment
Summary
To determine change of QTc interval during intravenous argatroban infusion in patients undergoing percutaneous coronary intervention (PCI)
Timeline
- Start
- 2017-04-18
- Primary completion
- 2021-05-06
- Completion
- 2021-05-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Argatroban | Small molecule | 20 ug/kg | Intravenous |